BusinessSchrödinger and MaRS Innovation Announce the Launch of Bright Angel TherapeuticsBy Nasdaq OMXDec 21, 2017, 1:00 PM UTC
BusinessApellis Finalizes Phase 3 Clinical Trial Plans for Geographic Atrophy Treatment with APL-2By Nasdaq OMXDec 20, 2017, 10:30 PM UTC
BusinessAmarantus Subsidiary MANF Therapeutics Announces Issuance of Japanese Patent Covering Therapeutic Use of MANF in Treatment of Parkinson's DiseaseBy Nasdaq OMXDec 20, 2017, 2:02 PM UTC
BusinessCannabisNewsWire Announces Publication on Revenue Potential for Specialty Biotech Companies in Explosive Medical Cannabis MarketBy Nasdaq OMXDec 20, 2017, 1:30 PM UTC
BusinessMetatron (MRNJ) Signs Deal with Lifestyle Company and update on Bitweed™ Crypto Platform with Vaporized Chat Private Security AppBy Nasdaq OMXDec 20, 2017, 12:00 PM UTC
BusinessLabCentral Gallery 1832 Features Large-Scale, Neo-Expressionist, Figurative Work by Boston-Area Artist, Sorin BicaBy Nasdaq OMXDec 19, 2017, 8:18 PM UTC
BusinessApellis Pharmaceuticals Expands Management Team, Appoints Timothy Sullivan Chief Financial OfficerBy Nasdaq OMXDec 19, 2017, 3:16 PM UTC
BusinessVBI Vaccines Announces Initiation of Phase 3 Clinical Program for Sci-B-Vac® Hepatitis B VaccineBy Nasdaq OMXDec 19, 2017, 1:00 PM UTC
